Clinical trial

Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes

NCT00791479

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-12-01

PhasePHASE2

Study timeline

Study start (unknown)2008-12-01Date precision: month

Registry last updated2014-12-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

LY2189265 and Lifestyle MeasuresDRUG

Placebo solution and Lifestyle MeasuresDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

CopenhagenDenmark2 MoscowRussia1 Saint PetersburgRussia1 MálagaSpain1 WichitaKansas, United States1 WroclawPoland1 BialystokPoland1 Mexico CityMexico1 ZagrebCroatia1 AarhusDenmark1 MonterreyMexico1 SzczecinPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00791479 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.